1. Home
  2. DFIN vs AMPH Comparison

DFIN vs AMPH Comparison

Compare DFIN & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DFIN
  • AMPH
  • Stock Information
  • Founded
  • DFIN 1983
  • AMPH 1996
  • Country
  • DFIN United States
  • AMPH United States
  • Employees
  • DFIN N/A
  • AMPH N/A
  • Industry
  • DFIN Other Consumer Services
  • AMPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • DFIN Consumer Discretionary
  • AMPH Health Care
  • Exchange
  • DFIN Nasdaq
  • AMPH Nasdaq
  • Market Cap
  • DFIN 1.4B
  • AMPH 1.3B
  • IPO Year
  • DFIN N/A
  • AMPH 2014
  • Fundamental
  • Price
  • DFIN $44.81
  • AMPH $27.80
  • Analyst Decision
  • DFIN Strong Buy
  • AMPH Hold
  • Analyst Count
  • DFIN 3
  • AMPH 3
  • Target Price
  • DFIN $71.33
  • AMPH $43.50
  • AVG Volume (30 Days)
  • DFIN 387.2K
  • AMPH 590.3K
  • Earning Date
  • DFIN 04-30-2025
  • AMPH 05-07-2025
  • Dividend Yield
  • DFIN N/A
  • AMPH N/A
  • EPS Growth
  • DFIN 13.76
  • AMPH 17.69
  • EPS
  • DFIN 3.06
  • AMPH 3.06
  • Revenue
  • DFIN $781,900,000.00
  • AMPH $731,967,000.00
  • Revenue This Year
  • DFIN $4.59
  • AMPH $2.60
  • Revenue Next Year
  • DFIN $4.40
  • AMPH $9.42
  • P/E Ratio
  • DFIN $14.59
  • AMPH $8.94
  • Revenue Growth
  • DFIN N/A
  • AMPH 13.59
  • 52 Week Low
  • DFIN $41.76
  • AMPH $25.89
  • 52 Week High
  • DFIN $71.01
  • AMPH $53.96
  • Technical
  • Relative Strength Index (RSI)
  • DFIN 38.83
  • AMPH 39.98
  • Support Level
  • DFIN $43.20
  • AMPH $28.01
  • Resistance Level
  • DFIN $46.51
  • AMPH $29.27
  • Average True Range (ATR)
  • DFIN 1.39
  • AMPH 0.82
  • MACD
  • DFIN 0.57
  • AMPH 0.28
  • Stochastic Oscillator
  • DFIN 64.28
  • AMPH 53.04

About DFIN Donnelley Financial Solutions Inc.

Donnelley Financial Solutions Inc is a risk and compliance solutions company. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. The company operates in four segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management, Investment Companies - Software Solutions and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States( USA), Europe, Asia, Canada, and others, of which the USA accounts for the vast majority of its total revenue.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: